These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30297082)

  • 1. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
    Melamed ML; Chonchol M; Gutiérrez OM; Kalantar-Zadeh K; Kendrick J; Norris K; Scialla JJ; Thadhani R
    Am J Kidney Dis; 2018 Dec; 72(6):834-845. PubMed ID: 30297082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
    Strugnell SA; Sprague SM; Ashfaq A; Petkovich M; Bishop CW
    Am J Nephrol; 2019; 49(4):284-293. PubMed ID: 30878999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
    Sprague SM; Crawford PW; Melnick JZ; Strugnell SA; Ali S; Mangoo-Karim R; Lee S; Petkovich PM; Bishop CW
    Am J Nephrol; 2016; 44(4):316-325. PubMed ID: 27676085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease.
    Sprague SM; Silva AL; Al-Saghir F; Damle R; Tabash SP; Petkovich M; Messner EJ; White JA; Melnick JZ; Bishop CW
    Am J Nephrol; 2014; 40(6):535-45. PubMed ID: 25572630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency.
    Galassi A; Ciceri P; Porata G; Iatrino R; Boni Brivio G; Fasulo E; Magagnoli L; Stucchi A; Frittoli M; Cara A; Cozzolino M
    Expert Opin Drug Saf; 2021 Nov; 20(11):1333-1349. PubMed ID: 33993809
    [No Abstract]   [Full Text] [Related]  

  • 7. Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease.
    Agarwal R; Georgianos PI
    Nephrol Dial Transplant; 2016 May; 31(5):706-13. PubMed ID: 27190392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
    Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
    J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D in Chronic Kidney Disease and Dialysis Patients.
    Jean G; Souberbielle JC; Chazot C
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28346348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ergocalciferol and cholecalciferol in CKD.
    Nigwekar SU; Bhan I; Thadhani R
    Am J Kidney Dis; 2012 Jul; 60(1):139-56. PubMed ID: 22560832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release calcifediol in stage 3-4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D.
    Cozzolino M; Minghetti P; Navarra P
    J Nephrol; 2022 Apr; 35(3):863-873. PubMed ID: 34626363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.
    Petkovich M; Melnick J; White J; Tabash S; Strugnell S; Bishop CW
    J Steroid Biochem Mol Biol; 2015 Apr; 148():283-9. PubMed ID: 25446887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24,25-Dihydroxy Vitamin D and Vitamin D Metabolite Ratio as Biomarkers of Vitamin D in Chronic Kidney Disease.
    Lee S; Chung HJ; Jung S; Jang HN; Chang SH; Kim HJ; Cho MC
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
    Ennis JL; Worcester EM; Coe FL; Sprague SM
    J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of 25-OH-vitamin D deficiency improves control of secondary hyperparathyroidism and reduces the inflammation in stable haemodialysis patients.
    Ojeda López R; Esquivias de Motta E; Carmona A; García Montemayor V; Berdud I; Martín Malo A; Aljama García P
    Nefrologia (Engl Ed); 2018; 38(1):41-47. PubMed ID: 28673686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
    Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of calcifediol supplementation on markers of chronic kidney disease-mineral and bone disorder in dogs with chronic kidney disease.
    Parker VJ; Rudinsky AJ; Benedict JA; Beizaei A; Chew DJ
    J Vet Intern Med; 2020 Nov; 34(6):2497-2506. PubMed ID: 33128421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
    Bishop CW; Strugnell SA; Csomor P; Kaiser E; Ashfaq A
    Am J Nephrol; 2022; 53(6):446-454. PubMed ID: 35551374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.